Etiology and mode of presentation of chronic liver diseases in India: A multi centric study
- PMID: 29073197
- PMCID: PMC5658106
- DOI: 10.1371/journal.pone.0187033
Etiology and mode of presentation of chronic liver diseases in India: A multi centric study
Abstract
There is a paucity of health policy relevant data for chronic liver disease from India, impeding formulation of an interventional strategy to address the issue. A prospective, multicentric study to delineate the etiology and clinical profile of chronic liver disease in India is reported here. A centrally coordinated and monitored web-based data repository was developed (Feb, 2010 to Jan, 2013) and analyzed. Eleven hospitals from different parts of India participated. Data were uploaded into a web based proforma and monitored by a single centre according to a standardized protocol. 1.28% (n = 266621) of all patients (n = 20701383) attending the eleven participating hospitals of India had liver disease. 65807 (24·68%) were diagnosed for the first time (new cases). Of these, 13014 (19·77%, median age 43 years, 73% males) cases of chronic liver disease were finally analyzed. 33.9% presented with decompensated cirrhosis. Alcoholism (34·3% of 4413) was the commonest cause of cirrhosis while Hepatitis B (33·3%) was predominant cause of chronic liver disease in general and non-cirrhotic chronic liver disease (40·8% out of 8163). There was significant interregional differences (hepatitis C in North, hepatitis B in East and South, alcohol in North-east, Non-alcoholic Fatty Liver Disease in West) in the predominant cause of chronic liver disease. Hepatitis B (46·8% of 438 cases) was the commonest cause of hepatocellular Cancer.11·7% had diabetes. Observations of our study will help guide a contextually relevant liver care policy for India and could serve as a framework for similar endeavor in other developing countries as well.
Conflict of interest statement
Figures
Similar articles
-
Trends of chronic liver disease in a tertiary care referral hospital in Eastern India.Indian J Public Health. 2014 Jul-Sep;58(3):186-94. doi: 10.4103/0019-557X.138630. Indian J Public Health. 2014. PMID: 25116825
-
Prevalence and presentation of hepatitis C related chronic liver disease in southern India.J Trop Med Hyg. 1995 Jun;98(3):161-5. J Trop Med Hyg. 1995. PMID: 7783272
-
Clinical profile of chronic hepatobiliary disorders in children: experience from tertiary referral centre in Western India.Trop Gastroenterol. 2010 Apr-Jun;31(2):108-10. Trop Gastroenterol. 2010. PMID: 20862985
-
Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.
-
Epidemics of venoocclusive disease in India and Afghanistan.Nutr Rev. 1978 Feb;36(2):48-9. doi: 10.1111/j.1753-4887.1978.tb07338.x. Nutr Rev. 1978. PMID: 345159 Review. No abstract available.
Cited by
-
What Are the Current Pharmacological Therapies for Nonalcoholic Fatty Liver Disease?J Clin Exp Hepatol. 2021 Mar-Apr;11(2):232-238. doi: 10.1016/j.jceh.2020.09.001. Epub 2020 Sep 3. J Clin Exp Hepatol. 2021. PMID: 33746449 Free PMC article. Review.
-
Correlation of Hepatic Venous Pressure Gradient Level With Clinical and Endoscopic Parameters in Decompensated Chronic Liver Disease.Cureus. 2023 Dec 27;15(12):e51154. doi: 10.7759/cureus.51154. eCollection 2023 Dec. Cureus. 2023. PMID: 38283456 Free PMC article.
-
Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety.Nutrients. 2021 May 24;13(6):1784. doi: 10.3390/nu13061784. Nutrients. 2021. PMID: 34073784 Free PMC article. Review.
-
Role of non-invasive markers in prediction of esophageal varices and variceal bleeding in patients of alcoholic liver cirrhosis from central India.Turk J Gastroenterol. 2019 Dec;30(12):1036-1043. doi: 10.5152/tjg.2019.18334. Turk J Gastroenterol. 2019. PMID: 31854309 Free PMC article.
-
Randomised clinical trial: effect of adding branched chain amino acids to exercise and standard-of-care on muscle mass in cirrhotic patients with sarcopenia.Hepatol Int. 2022 Jun;16(3):680-690. doi: 10.1007/s12072-022-10334-7. Epub 2022 Apr 25. Hepatol Int. 2022. PMID: 35469091 Free PMC article. Clinical Trial.
References
-
- Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371:838–851. doi: 10.1016/S0140-6736(08)60383-9 - DOI - PMC - PubMed
-
- Propst A, Propst T, Zangerl G, Ofner D, Judmaier G, Vogel W. Prognosis and life expectancy in chronic liver disease. Dig Dis Sci 1995;40(8):1805–15 - PubMed
-
- Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 2014;12:145 doi: 10.1186/s12916-014-0145-y - DOI - PMC - PubMed
-
- Byass P. The global burden of liver disease: a challenge for methods and for public health. BMC medicine 2014;12:159 doi: 10.1186/s12916-014-0159-5 - DOI - PMC - PubMed
-
- GBD 2013 Mortality and Causes of Death Collaborators. GBD 2013 Mortality and Causes of Death collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117–171. doi: 10.1016/S0140-6736(14)61682-2 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical